Pfizer Inc (NYSE:PFE)
| 39.99 BATS BZX Real-Time Price As of 11:43am ET |  -0.72 / -1.77%Today’s Change | 33.97 Today|||52-Week Range 44.56 | +2.07% Year-to-Date |
Latest PFE News | Press Releases
| Pfizer to Market Viagra Through Roman's Telehealth Service Jan 23 / MotleyFool.com - Paid Partner Content | New Research Shows Probiotics Can Help Prevent Parkinson's Jan 14 / MotleyFool.com - Paid Partner Content |
| AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate Cancer Jan 21 / MotleyFool.com - Paid Partner Content | Will Theravance Biopharma Finally Break Out in 2020? Jan 14 / MotleyFool.com - Paid Partner Content |
| 2 Biotechs Battling Immune Diseases Jan 19 / MotleyFool.com - Paid Partner Content | Is Pfizer's Stock a Buy? Jan 14 / MotleyFool.com - Paid Partner Content |
| Why Pfizer Stock Fell 10.2% in 2019 Jan 16 / MotleyFool.com - Paid Partner Content | Biogen Buys Azheimer's and Parkinson's Drug From Pfizer Jan 13 / MotleyFool.com - Paid Partner Content |
| 5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals Jan 16 / MotleyFool.com - Paid Partner Content | Here's Why SpringWorks Therapeutics Climbed 69% in December Jan 12 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 40.71 |
| Today’s open | 40.87 |
| Day’s range | 39.96 - 40.95 |
| Volume | 11,199,558 |
| Average volume (3 months) | 18,746,824 |
| Market cap | $224.2B |
Data as of 11:43am ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | -46.78% |
| Earnings growth (this year) | -1.03% |
| Earnings growth (next 5 years) | +6.70% |
| Revenue growth (last year) | +2.10% |
| P/E ratio | 14.0 |
| Price/Sales | 4.86 |
| Price/Book | 3.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRKMerck | -1.72 | -1.94% |
| NVSNovartis | -0.90 | -0.95% |
| BMYBristol-Myers Squibb | -2.70 | -4.04% |
| LLYEli Lilly and Co | -1.25 | -0.89% |
Data as of 11:43am ET, 01/24/2020
Financials
| Next reporting date | January 28, 2020 |
| EPS forecast (this quarter) | $0.58 |
| Annual revenue (last year) | $53.6B |
| Annual profit (last year) | $11.2B |
| Net profit margin | 20.77% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
